Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin
NCT02076347 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 489
Last updated 2015-10-19
Summary
The purpose of this project is to compare two pharmacist-led population management strategies designed to increase the rate of appropriate monitoring of vitamin B12 and serum creatinine for patients taking metformin.
Conditions
- Type 2 Diabetes
- Vitamin B12 Deficiency
- Neuropathy
- Anemia
Interventions
- BEHAVIORAL
-
Office visit intervention
Pharmacist communicates monitoring recommendations to physician through the electronic medical record prior to a scheduled patient office visit
- BEHAVIORAL
-
Electronic Message Intervention
Pharmacist communicates need for monitoring directly to patients and instructs them to obtain monitoring on their own time without need for an office visit with physician
Sponsors & Collaborators
-
Ohio State University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2014-08-31
- Completion
- 2015-10-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy Study of Metformin Glycinate on Postprandial Lipemia
NCT02064881 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study to Assess the Food Effect on Bioavailability of Metformin/Gliclazide in Healthy Participants
NCT03467971 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Metformin on Insulin Sensitivity and Pan-Arterial Vascular Function in Adults With Metabolic Syndrome
NCT02633488 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With Vandetanib
NCT01551615 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Learn More About Outcomes Reported by Patients Suffering From Type 2 Diabetes Using a Digital Data Collection Tool
NCT04383041 ·Status: COMPLETED
-
Pharmacokinetic-Pharmacodynamic Relationship of Metformin in Healthy Volunteers
NCT02712619 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients
NCT02151461 ·Status: COMPLETED ·Phase: PHASE2
-
A Pharmacokinetic Evaluation of Metformin in Relation to the Polymorphism A270S in Healthy Caucasian Volunteers
NCT01237522 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /Metformin
NCT01540487 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of a Linagliptin+Metformin Fixed Dose Combination Tablet Administered With and Without Food to Healthy Male and Female Subjects
NCT02223026 ·Status: COMPLETED ·Phase: PHASE1
-
Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease
NCT06932874 ·Status: RECRUITING ·Phase: PHASE4
-
Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)
NCT00543361 ·Status: TERMINATED ·Phase: PHASE3
-
OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck.
NCT01842620 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin
NCT01929863 ·Status: COMPLETED ·Phase: PHASE2
-
The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
NCT00546728 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate Whether Pharmacokinetic and Pharmacodynamic Interactions Exist Between Metformin and Canagliflozin (JNJ-28431754) in Healthy Volunteers
NCT01756417 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers
NCT01489644 ·Status: COMPLETED ·Phase: PHASE1
-
Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex I
NCT03445702 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Myo-inositol Versus Metformin Administration in Post-menopausal Women With Metabolic Syndrome
NCT01046500 ·Status: UNKNOWN ·Phase: PHASE2
-
Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability
NCT01211197 ·Status: COMPLETED ·Phase: PHASE1
-
Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers
NCT05125575 ·Status: COMPLETED ·Phase: PHASE1
-
A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions
NCT00865033 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263
NCT01128621 ·Status: COMPLETED ·Phase: PHASE2
-
Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions
NCT03684707 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
NCT03686722 ·Status: COMPLETED ·Phase: PHASE1